Andrew M. Dahl - 13 Sep 2024 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role: SVP, Corporate Controller
Signature: Linda J. Park, Attorney-in-Fact
Issuer symbol: EW
Transactions as of: 13 Sep 2024
Net transactions value: $0
Form type: 4
Filing time: 16 Sep 2024, 17:25:57 UTC
Previous filing: 01 Jul 2024
Next filing: 24 Feb 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EW	Common Stock	Award	$0	+2,920	+165%	$0.000000	4,691	13 Sep 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These restricted stock units were granted on September 13, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. This Form 4 includes quarterly acquisition of shares under the Issuer's Employee Stock Purchase Plan.